We are developing therapeutics for the management and treatment of Alzheimer's Disease and Chronic Spinal Cord Injury with IP licensed from Yale.,
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free